F.D.A. Approves New H.I.V.-Prevention Drug, but Not for Women by BY APOORVA MANDAVILLI


Citing a lack of evidence, the agency will require Gilead to conduct further trials in women.

Published: October 4, 2019 at 08:24PM

from NYT Health https://ift.tt/31OwHFd